Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Missouri for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Missouri only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Missouri (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Nicholas Chinskey (NPI 1174847941)

Field	Value
Entity Type	Individual
Organization	Nicholas Chinskey
Address	17 The Boulevard
City	St Louis
State	MO
ZIP	63117
Taxonomy	Ophthalmology Physician
NPI Enumerated	March 22, 2010

Payer Source	Total Paid
Medicare	$2.5M
Medicaid	$0

Key Findings

This provider is effectively single‑payer at scale: total Medicare revenue is $2.5M and there is no Medicaid billing on file, so Medicare drives the entire documented public-payer footprint for this NPI. The absence of Medicaid billing means any Medicaid-covered case volume or risk is either negligible or billed under different NPIs or group arrangements.

Revenue is highly concentrated in intravitreal biologic injections: the precomputed top‑3 Medicare codes account for 70.2% of Medicare revenue, led by J0178 (1.4K claims, $693 avg paid/claim, $1M revenue, 40.1%), J2778 (2.9K claims, $187 avg paid/claim, $549.4K revenue, 22.0%), and Q5128 (938 claims, $215 avg paid/claim, $201.7K revenue, 8.1%). This concentration indicates a practice model heavily dependent on high-cost ophthalmic injectables rather than a broad mix of non-drug procedures.

Clinical mix and procedure profile align with a retina-focused ophthalmology practice: frequent use of J0178, J2778, Q5128 and procedure 67028 (2K claims, $91 avg paid/claim, $178.1K revenue, 7.1%) shows regular isolated intravitreal injections, while diagnostic codes such as 92134 (2.7K claims, $34 avg paid/claim, $90.1K revenue, 3.6%) point to high volumes of retinal imaging to support injection-based care. Together these codes signal longitudinal management of retinal disease (e.g., wet AMD, diabetic macular edema) with integrated imaging and injection workflows.

Competitive standing is mixed by code: the provider ranks relatively high among ranibizumab billers (J2778 ranks #122 of 1208 providers nationally, 90th percentile), indicating a major participant for that drug, while J0178 (aflibercept) ranks #864 of 3204, 73th percentile, which is above typical but not dominant nationally; Q5128 (biosimilar ranibizumab‑eqrn) ranks #145 of 373, 61th percentile, indicating a modest presence for that biosimilar. In short, the provider is a strong regional player for ranibizumab and a solid but not leading participant among aflibercept injectors.

Several utilization metrics are statistical outliers on the high side for outpatient throughput: 99213 (1.3K claims, $72 avg paid/claim, $94.6K revenue) and 99204 (235 claims, $129 avg paid/claim, $30.3K revenue) both carry the supplied label "extreme outlier, far above typical national volume," and 92134 is also labeled an "extreme outlier." These high percentiles for standard E/M and retinal imaging suggest unusually high visit and diagnostic volumes that support the injection-centric revenue base.

Adoption of newer or alternative injectable agents appears limited or variable: J2777 (faricimab) shows 5K claims but a low avg paid/claim ($29) and ranks in the 25th percentile nationally, described as "typical, unremarkable volume," which may indicate constrained reimbursement for that code or differing billing patterns; J3590 (unclassified biologics) is small (25 claims, $2120 avg paid/claim, $53K revenue) and ranks in the 13th percentile, indicating limited use of unclassified biologics relative to peers. These patterns suggest the practice favors established anti‑VEGF agents while newer or atypical biologics play a smaller role.

Practice tenure and implied stability: the NPI was enumerated on 2010-03-22 (~16 years ago), indicating a long-standing presence in the market. Coupled with $2.5M in lifetime Medicare revenue and sustained high volumes on core E/M, imaging, and injection codes, the data point to an established clinical operation with persistent demand for retina services.

Concentration risk and strategic implications: with injections and associated imaging dominating revenue (top three codes = 70.2% of Medicare revenue), the practice is exposed to drug‑specific reimbursement and utilization changes. At the same time, the very high E/M and imaging volumes present an operational opportunity to diversify revenue within ophthalmic procedures and ancillary services if payer coverage or drug mix shifts occur.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

20 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,440	$690	$1M
J2778	Injection, ranibizumab, 0.1 mg	2,940	$190	$549.4K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	940	$220	$201.7K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,960	$90	$178.1K
J2777	Injection, faricimab‑svoa, 0.1 mg	4,980	$30	$144.4K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	1,310	$70	$94.6K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,650	$30	$90.1K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	910	$100	$88.8K
J3590	Unclassified biologics	30	$2,120	$53K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	240	$130	$30.3K

Showing 1–10 of 20

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 20 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Missouri Distribution

Nicholas Chinskey — 5 of 20 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Missouri

Full comparison — all codes billed, vs. state median

20 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	13	60	820	$690	$683.3K
J2777	38	50	11,730	$30	$388.9K
J2778	2	20	540	$180	$203.8K
Q5128	2	10	940	$220	$153.4K
67028	7	80	600	$90	$69.7K
J3590	28	30	80	$160	$19K
92014	31	730	120	$80	$18K
J7999	3	10	40	$50	$12.7K
92012	139	330	70	$60	$8.8K
99213	35	8,730	70	$50	$7K

Showing 1–10 of 20

Related Providers

Other providers that share a Tax Identification Number (TIN) with Nicholas Chinskey, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Associated Retinal Consultants LLC	DE	Ophthalmology Physician	$0	$25.2M
Rutgers Health-rwj Pediatric Critical Care	NJ	Emergency Medical Services (Emergency Medicine) Physician	$0	$8.1M
Rutgers Health-rwj Pediatric Critical Care	NJ	Pediatric Emergency Medicine (Pediatrics) Physician	$0	$7.3M
Rohit Lakhanpal	MD	Retina Specialist (Ophthalmology) Physician	$6.1M	$0
Vinod Voleti	NJ	Retina Specialist (Ophthalmology) Physician	$4.1M	$0
Sumit Shah	NJ	Retina Specialist (Ophthalmology) Physician	$4.1M	$0
Newman Sund	MD	Ophthalmology Physician	$4M	$0
Eric Suan	MD	Ophthalmology Physician	$3.8M	$0
Matthew Speicher	MD	Ophthalmology Physician	$3.7M	$0
Howard Fine	NJ	Retina Specialist (Ophthalmology) Physician	$3.6M	$0

Nearby Providers

Other providers in the same ZIP code as Nicholas Chinskey, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Ssm Health Care St. Louis	MO	General Acute Care Hospital	$0	$50.1M
5 Star Home Care Services LLC	MO	Home Health Agency	$0	$9.3M
Medstar Home Health Services LLC	MO	Home Health Agency	$0	$7.3M
Cep America LLC	MO	Emergency Medicine Physician	$0	$4M
Raymond Leung	MO	Internal Medicine Physician	$15.6K	$429.9K
Waseem Ansari	MO	Ophthalmology Physician	$434.7K	$0
Kelvin Mcdaniel	MO	Ophthalmology Physician	$363K	$0
Sean Breit	MO	Ophthalmology Physician	$357.5K	$0
Paul Catanzaro	MO	Internal Medicine Physician	$316.1K	$0
Jeramie Rosales Rodriguez	MO	Psychiatry Physician	$2.1K	$289.9K

Nicholas Chinskey — Billing Profile & Reimbursement Data

Sign up for Nicholas Chinskey — Billing Profile & Reimbursement Data policy alerts

Nicholas Chinskey — Billing Profile & Reimbursement Data

Sign up for Nicholas Chinskey — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References